Skip to main content

Table 6 New specifications for product release

From: Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function

  % Lymphocytes % Monocytes % Granulocytes PLT/WBC
Current specification ≥ 25 ≥ 4 ≤ 75 ≤ 40
Updated specification ≥ 30 ≥ 8 ≤ 55 ≤ 10
  1. PLT: Platelets; WBC: White Blood Cells.
\